Categories
Profile

Corinne Trim, MBA

Corinne has over 25 years experience within the NHS working across a variety of healthcare organizations spanning primary care, community mental health, commissioners and more recently for three large teaching hospitals in London.  Joining the NHS as an ICT Project Manager Corinne has developed her portfolio in education and training, leading to her current role as Education and Training Lead for the NTGLH. 

Over the past 15 years Corinne has worked as a Senior Education and Training Manager, at King’s College Hospital and at Barts Health NHS Trust; during this time being heavily involved in the quality assurance of medical education and training as a Lay Chair for the London Deanery (as was) and as a GMC Partner.  As an honorary lecturer Corinne has developed academic programmes with King’s College London and Queen Mary University of London.

Categories
Profile

Mrs Lucy Jenkins

Lucy Jenkins is Rare Disease Laboratory Lead and Consultant Clinical Scientist for the Rare & Inherited Disease Laboratory based at Great Ormond Street Hospital in London. After graduating in Molecular Biology from Liverpool University, Lucy has worked as a clinical scientist since 1992, moving from the Yorkshire Regional DNA Laboratory in Leeds to Great Ormond Street in 2000 and obtaining Fellowship of the Royal College of Pathologists in 2006. During her career, Lucy has developed a range of molecular genetic services and is now responsible for delivery of 11 out of the 16 NHSE specialist genomic services for the London North GLH. Translation of Next Generation Sequencing technologies into NHS diagnostic service with cell free fetal DNA analysis for non-invasive prenatal diagnosis (NIPD) are particular areas of focus for the laboratory. In a professional capacity, Lucy is an examiner for the Royal College of Pathologists and plays an active role in external quality assessment through EMQN and GENQA.

Categories
Profile

Dr Michael Hubank

Dr Michael Hubank is Head of Clinical Genomics (Research) at The Royal Marsden NHS Foundation Trust, with an Honorary Readership in Translational Genomics at the Institute of Cancer Research (ICR).  Dr Hubank graduated from the University of Cambridge with a degree in Natural Sciences and in 1990 gained a PhD in Molecular Endocrinology from University College London (UCL).  He began his appointments at the Royal Marsden and ICR in 2016 and now leads their Clinical Genomics Translational Research Team, establishing new genomic assays, and developing and applying diagnostic testing for clinical trials and research studies across the cancer field.

In his role as Scientific Director, he will seek to make the most advanced clinical diagnostic methods available to all NHS patients in a cost-effective and equitable manner. He is particularly interested in implementing genomic testing for circulating tumour DNA in clinically relevant settings, especially for diagnosis and prognosis in paediatric solid tumours, an area of cancer in severe need of better treatment options.

Categories
Profile

Julie Howard-Reeves

I am a Consultant Clinical Scientist in Clinical Genomics at the Royal Marsden Hospital and I am the Operational Lead and Head Scientist (cancer lab) for the London North Genomics Laboratory Hub. I have over 25 years of experience in Clinical Genomics with a particular interest in cancer genetics. I am responsible for the oncology diagnostic service for cancer testing as part of the NHS Genomic Medicine service as well as the general management of the London North Cancer laboratory, I work closely with the Scientific Director for the GLH for the strategic development of the service and related research interests across the GLH. Other professional activities I am involved in include examiner in genetics for the Royal College of Pathologists, committee member for the ACGS quality sub-committee and UKAS technical assessor for genetics.

Categories
Profile

Kajal Joshi

I’m proud to have been part of the NHS family for over 10 years now, working in a range of project management roles and now specialising in ICT Projects. During my time, I’ve been fortunate enough to have worked on a number of high profile projects, beginning with the deployment of the Electronic Prescription Service within NWL & Barnet CCG during a critical launch phase. On joining the wonderful team at Great Ormond Street Hospital, I worked on several redevelopment projects including parental accommodation, office spaces, nursery relocation and the setup of our new executive office and meeting spaces. Most recently I’ve worked on the implementation of the CP-IS (Child Protection – Information Sharing) national programme across GOSH.


At London North, my role will be to support the NGIS project, collaborations with the laboratories and the ICT requirements overall. I look forward to contributing to the vital work and changes at London North in the future.

Categories
Profile

Professor Lyn Chitty

Professor Chitty is in the unique position of being the only UK Professor of Genetics and Fetal Medicine, and was appointed to this chair at the UCL Great Ormond Street Institute of Child Health in 2009.

She is also Consultant in Fetal Medicine at UCLH NHS Foundation Trust. She has published extensively on prenatal diagnosis and ultrasound screening of fetal abnormalities, specifically skeletal abnormalities, and was responsible for creating the fetal size standards now in use throughout the UK and beyond.

Her main current research interest is prenatal genetic diagnosis based on analysis of cell free DNA in maternal blood. She led the NIHR-funded programme which developed the standards for routine implementation of this exciting new technology.

Categories
Profile

Dr Daniel Gale

Daniel Gale is the St Peter’s Associate Professor of Nephrology at the UCL Department of Renal Medicine, Royal Free Hospital where he leads the North/Central Thames renal genetics service, delivering specialised care for patients and families with hereditary kidney problems including polycystic kidney disease, aHUS, Alport Syndrome and unexplained familial kidney failure.

He described and identified the molecular defects responsible for the genetic diseases HIF2α erythrocytosis with pulmonary hypertension, which results from a defect in cellular oxygen sensing, and CFHR5 nephropathy, which results from a defect of complement regulation and is endemic in people of Cypriot ancestry.

He also oversees the RaDaR rare renal disease registry of 25,000 patients with rare kidney diseases from across the UK.

Categories
Profile

Dr Vaneesha Gibbons

As Quality Lead for the North London GLH my focus is to develop an integrated quality, safety and risk management system across our hub.

Genetic testing provided by the laboratories in our GLH is accredited to current ISO15189 standards for medical laboratories, so the bar is already set high.

By sharing tried and tested systems and processes in use within the hub as well as learning from our challenges, we can target adaptions to our respective Quality Management Systems to add value to our services. 

To deliver this complex service there are multiple stakeholders with their own demands and limitations.

Effective responses to these demands and limitations are managed by gearing them towards the needs and requirements of our end users: the clinical teams and their patients.

The goals to build state of the art genomic services using new and emerging technologies at high throughput, with value for money to improve patient outcomes will be underpinned by rigorous implementation of the highest standards of quality.